Nonlinear growth kinetics of breast cancer stem cells: Implications for cancer stem cell targeted therapy

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Liu, Xinfeng ^a   Johnson, Sara ^a   Liu, Shou ^a   Kanojia, Deepak ^a   Yue, Wei ^b   Singn, Udai ^c   Wang, Qian ^a   Nie, Qing ^d   Chen, Hexin ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

APOPTOSIS; BIOLOGICAL MODEL; BREAST NEOPLASMS; CANCER STEM CELL; CELL COMMUNICATION; CELL PROLIFERATION; COMPUTER SIMULATION; DRUG DELIVERY SYSTEM; DRUG EFFECTS; NONLINEAR SYSTEM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL COMMUNICATION; CELL PROLIFERATION; COMPUTER SIMULATION; DRUG DELIVERY SYSTEMS; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; NONLINEAR DYNAMICS;

EID: 84883193749     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02473     Document Type: Article

References (50)

1. Clarke, M. F. et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66, 9339-9344 (2006). (Pubitemid 44623625)
2. Shipitsin, M. et al.Molecular definition of breast tumor heterogeneity. Cancer Cell 11, 259-273 (2007). (Pubitemid 46349843)
3. Pece, S. et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140, 62-73 (2010).
4. Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499-507 (2008). (Pubitemid 351601215)
5. Visvader, J. E.& Lindeman, G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755-768 (2008).
6. Tan, B. T., Park, C. Y., Ailles, L. E. & Weissman, I. L. The cancer stem cell hypothesis: a work in progress. Lab. Invest. 86, 1203-1207 (2006). (Pubitemid 44789910)
7. Dalerba, P., Cho, R. W. & Clarke, M. F. Cancer stem cells: models and concepts. Annu. Rev. Med. 58, 267-284 (2007). (Pubitemid 46706514)
8. Hill, R. P. & Perris, R. "Destemming" cancer stem cells. J. Natl. Cancer Inst. 99, 1435-1440 (2007).
9. Lobo, N. A., Shimono, Y., Qian, D. & Clarke, M. F. The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 23, 675-699 (2007).
10. Al-Hajj, M.,Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100, 3983-3988 (2003). (Pubitemid 36418143)
11. Iliopoulos, D., Hirsch, H. A., Wang, G. & Struhl, K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc. Natl. Acad. Sci. U. S. A. 108, 1397-1402 (2011).
12. Ailles, L. E. & Weissman, I. L. Cancer stem cells in solid tumors. Curr. Opin. Biotechnol. 18, 460-466 (2007). (Pubitemid 350116595)
13. Cicalese, A. et al. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138, 1083-1095 (2009).
14. Mackillop, W. J., Ciampi, A., Till, J. E. & Buick, R. N. A stem cell model of human tumor growth: implications for tumor cell clonogenic assays. J. Natl. Cancer Inst. 70, 9-16 (1983). (Pubitemid 13138325)
15. Gupta, P. B. et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146, 633-644 (2011).
16. Boman, B. M.,Wicha, M. S., Fields, J. Z. & Runquist, O. A. Symmetric division of cancer stem cells-a key mechanism in tumor growth that should be targeted in future therapeutic approaches. Clin. Pharmacol. Ther. 81, 893-898 (2007). (Pubitemid 46788302)
17. Sehl, M. E., Sinsheimer, J. S., Zhou, H. & Lange, K. L. Differential destruction of stem cells: implications for targeted cancer stem cell therapy. Cancer Res. 69, 9481-9489 (2009).
18. Zhu, X., Zhou, X., Lewis, M. T., Xia, L. & Wong, S. Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational simulation study. J. Theor. Biol. 269, 138-149 (2010).
19. Rodriguez-Brenes, I. A., Komarova, N. L. &Wodarz, D. Evolutionary dynamics of feedback escape and the development of stem-cell-driven cancers. Proc. Natl. Acad. Sci. U. S. A. 108, 18983-18988 (2011).
20. Lander, A. D., Gokoffski, K. K.,Wan, F. Y., Nie, Q. & Calof, A. L. Cell lineages and the logic of proliferative control. PLoS Biol. 7, e15 (2009).
21. Deleyrolle, L. P. et al.Determination of somatic and cancer stem cell self-renewing symmetric division rate using sphere assays. PLoS ONE 6, e15844 (2011).
22. Selby, P., Bizzari, J. P. & Buick, R. N. Therapeutic implications of a stem cell model for human breast cancer: a hypothesis. Cancer Treat. Rep. 67, 659-663 (1983). (Pubitemid 13001712)
23. Morton, C. I., Hlatky, L., Hahnfeldt, P. & Enderling, H. Non-stem cancer cell kinetics modulate solid tumor progression. Theor. Biol. Med. Model. 8, 48 (2011).
24. Schober, M. & Fuchs, E. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-beta and integrin/focal adhesion kinase (FAK) signaling. Proc. Natl. Acad. Sci. U. S. A. 108, 10544-10549 (2011).
25. Norton, L., Simon, R., Brereton, H. D. & Bogden, A. E. Predicting the course of Gompertzian growth. Nature 264, 542-545 (1976).
26. Norton, L. A Gompertzian model of human breast cancer growth. Cancer Res. 48, 7067-7071 (1988). (Pubitemid 19013983)
27. Brunner, N. et al. Characterization of the T61 human breast carcinoma established in nude mice. Eur. J. Cancer Clin. Oncol. 21, 833-843 (1985). (Pubitemid 15028510)
28. Lo, W. C. et al. Feedback regulation in multistage cell lineages. Math. Biosci. Eng. 6, 59-82 (2009).
29. Johnston, M. D., Edwards, C. M., Bodmer, W. F., Maini, P. K. & Chapman, S. J. Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. Proc. Natl. Acad. Sci. U. S. A. 104, 4008-4013 (2007). (Pubitemid 47181569)
30. O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110 (2007). (Pubitemid 46067310)
31. Magnifico, A. et al. Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab. Clin. Cancer Res. 15, 2010-2021 (2009).
32. Korkaya, H., Paulson, A., Iovino, F. &Wicha, M. S. HER2 regulates themammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 27, 6120-6130 (2008).
33. Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270 (2003). (Pubitemid 36583168)
34. Dontu, G. &Wicha, M. S. Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia. J. Mammary Gland Biol. Neoplasia 10, 75-86 (2005). (Pubitemid 40724024)
35. Gu, Y. et al. The effect of B27 supplement on promoting in vitro propagation of Her2/neu-transformed mammary tumorspheres. J. Biotech. Res. 3, 7-18 (2011).
36. Iliopoulos, D., Hirsch, H. A. & Struhl, K. An epigenetic switch involving NFkappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139, 693-706 (2009).
37. Cariati, M. et al. Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int. J. Cancer 122, 298-304 (2008). (Pubitemid 350234715)
38. Yu, F. et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109-1123 (2007). (Pubitemid 350235025)
39. Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760 (2006). (Pubitemid 44949604)
40. Li, X. et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl. Cancer Inst. 100, 672-679 (2008).
41. Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancerinitiating cells. Nature 445, 111-115 (2007). (Pubitemid 46067311)
42. Steel, G. G., Adams, K. & Stephens, T. C. Clonogenic assays in the B16 melanoma: response to cyclophosphamide. Br. J. Cancer 36, 618-624 (1977). (Pubitemid 8215657)
43. Hewitt, H. B., Blake, E. & Proter, E. H. The effect of lethally irradiated cells on the transplantability of murine tumours. Br. J. Cancer 28, 123-135 (1973).
44. Scheel, C. et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145, 926-940.
45. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008). (Pubitemid 351636299)
46. Stuelten, C. H. et al. Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel. Stem cells 28, 649-660 (2010).
47. Norton, L. Cancer stem cells, self-seeding, and decremented exponential growth: theoretical and clinical implications. Breast Dis. 29, 27-36 (2008).
48. Norton, L. Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy. The oncologist 10, 370-381 (2005). (Pubitemid 40993565)
49. Benz, C. C. et al. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res. Treat. 24, 85-95 (1992). (Pubitemid 23063891)
50. Chen, H. et al. Proteomic characterization of Her2/neu-overexpressing breast cancer cells. Proteomics 10, 3800-3810 (2010).